Unlock instant, AI-driven research and patent intelligence for your innovation.

Method for improving multiplication capacity and performance of umbilical blood endothelial cells

A technology of endothelial cell proliferation and endothelial cells, which is applied in the field of improving the proliferation ability and performance of umbilical cord blood endothelial cells, so as to improve the therapeutic effect, enhance the angiogenesis ability of cells, and reduce the amount of cells

Inactive Publication Date: 2021-01-12
广州市天河诺亚生物工程有限公司
View PDF1 Cites 0 Cited by
  • Summary
  • Abstract
  • Description
  • Claims
  • Application Information

AI Technical Summary

Problems solved by technology

[0003] Although umbilical cord blood endothelial cells have many advantages compared with peripheral blood endothelial cells, their indications are mostly degenerative diseases, such as cardiovascular and cerebrovascular diseases, diabetic foot, etc., requiring long-term multiple infusions, and the amount of cells becomes The bottleneck of its application

Method used

the structure of the environmentally friendly knitted fabric provided by the present invention; figure 2 Flow chart of the yarn wrapping machine for environmentally friendly knitted fabrics and storage devices; image 3 Is the parameter map of the yarn covering machine
View more

Image

Smart Image Click on the blue labels to locate them in the text.
Viewing Examples
Smart Image
  • Method for improving multiplication capacity and performance of umbilical blood endothelial cells
  • Method for improving multiplication capacity and performance of umbilical blood endothelial cells
  • Method for improving multiplication capacity and performance of umbilical blood endothelial cells

Examples

Experimental program
Comparison scheme
Effect test

Embodiment 1

[0033]This embodiment provides a method for improving the proliferation ability and performance of cord blood endothelial cells, and the specific steps are as follows:

[0034]Umbilical cord blood and umbilical cord specimens were obtained from placenta delivered by healthy mothers through aseptic operations. The tests for hepatitis B, hepatitis C, syphilis, AIDS, cytomegalovirus, TORCH, mycoplasma, chlamydia, G-6PD, and thalassaemia were all negative. After the specimens are collected, they are transported back to the blood bank to maintain 4~8℃ transportation conditions. Follow the methods below:

[0035]Step 1. Preparation of umbilical cord mesenchymal stem cells

[0036]Mesenchymal stem cells are extracted from the umbilical cord tissue of healthy people, and the obtained mesenchymal stem cells are cultured and expanded in vitro. After the primary cells are collected, they are subcultured in a ratio of 1:3. When the cells are about 80% of the density at the bottom of the bottle, trypsin ...

Embodiment 2

[0056]Example 2 Identification of Mesenchymal Stem Cells and Endothelial Cells

[0057]1. Identify mesenchymal stem cells and endothelial cells

[0058]1) Mesenchymal stem cells are identified by the following methods

[0059]a) Morphological analysis and cell counting of mesenchymal stem cells: Observe the cell status on an inverted microscope and take pictures of the cells cultured to the second generation.

[0060]b) Phenotype determination by flow cytometry: Take the second generation cells, collect them by 0.25% trypsinization, and wash them twice with normal saline by centrifugation. Add mouse IgG-FITC and IgG-PE (BD Company, USA) to the isotype control tube, and add mouse anti-human CD105-PE, CD90-FITC, CD73-PE, CD45-FITC, and CD34-PE to the detection tube (BD Company, USA) ) 5μL each. Incubate at room temperature for 30 min in the dark, and detect by flow cytometry (Fascalibur, BD Company, USA).

[0061]2) Identification of endothelial cells by the following methods

[0062]a) Morphological ...

Embodiment 3

[0068]Example 3 Effect verification

[0069]To verify the proliferation of cells co-cultured with endothelial cells and mesenchymal cells and their ability to form blood vessels, the details are as follows:

[0070]Grouping design: mixed group (group A, cells co-cultured with endothelial cells and mesenchymal cells), endothelial cell group (OEC group or B group) and mesenchymal stem cell group (MSC group or C group).

[0071]Refer to Example Step 3: OEC group took 2 mL of cell suspension A and added 8 mL of endothelial cell culture medium. In the MSC group, 2 mL of cell suspension B was added to 8 mL of endothelial cell culture medium. In the mixed group A, 2 mL of cell suspension A and cell suspension B were added to 6 mL of endothelial cell culture medium. The three groups were added to T75 culture flasks pre-plated with collagen and cultured. This experiment was repeated 3 times, and the results of each experiment were analyzed according to Example 3, Example 4, and Example 5.

[0072]1. Ve...

the structure of the environmentally friendly knitted fabric provided by the present invention; figure 2 Flow chart of the yarn wrapping machine for environmentally friendly knitted fabrics and storage devices; image 3 Is the parameter map of the yarn covering machine
Login to View More

PUM

No PUM Login to View More

Abstract

The invention discloses a method for improving the multiplication capacity and performance of umbilical blood endothelial cells. The method comprises the following steps: separating and purifying umbilical blood source endothelial cells from fresh umbilical blood, and carrying out mixed culture on the umbilical blood source endothelial cells and umbilical cord source mesenchymal stem cells. By adopting the method disclosed by the invention, the purpose of improving the multiplication efficiency and the vascular forming capacity of the umbilical blood endothelial cells is achieved. After the method disclosed by the invention is applied, due to the down-regulation effect of the mesenchymal stem cells and expansion of the total cell quantity of treatment, the proportion of cells lost due to immune reaction is reduced, the treatment effect is ensured, and the application possibility of the umbilical blood source endothelial cells is enhanced. The mesenchymal stem cells also have the capacity of assisting in maintaining blood vessels, and a guarantee is provided for the long-term treatment effect. The method disclosed by the invention is mainly applied to the umbilical blood endothelialcells in the aspects of vascular repair treatment, tissue engineering and the like.

Description

Technical field[0001]The invention belongs to the field of cell therapy, and particularly relates to a method for improving the proliferation ability and performance of cord blood endothelial cells.Background technique[0002]Outgrowth endothelial cells (OEC), belonging to vascular endothelial precursor cells, grow like paving stones when cultured in vitro, forming a cell monolayer, which is consistent with the shape of mature endothelial cells, but has the ability to rapidly expand and generate blood vessels , Making it a new favorite in the field of cell therapy, researchers hope to use it for the treatment of cardiovascular and cerebrovascular diseases, heart disease, limb ischemia and other diseases. Jumi Kim et al. (Jumi Kim, Young-Joo Jeon.Comparative proteomic analysis of endothelial cells progenitor cells derived from cordblood-and peripheral blood for cell therapy.Biomaterials.Volume 34, Issue 6, February 2013, Pages 1669--1685.) The difference between blood endothelial cells...

Claims

the structure of the environmentally friendly knitted fabric provided by the present invention; figure 2 Flow chart of the yarn wrapping machine for environmentally friendly knitted fabrics and storage devices; image 3 Is the parameter map of the yarn covering machine
Login to View More

Application Information

Patent Timeline
no application Login to View More
IPC IPC(8): C12N5/071C12N5/0775
CPCC12N5/069C12N2502/137C12N2509/00C12N2509/10
Inventor 魏伟嵐山芮许超
Owner 广州市天河诺亚生物工程有限公司